NATURE’S SUNSHINE PRODUCTS, INC. Debt Securities, Trading, Realized Gain
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Debt Securities, Trading, Realized Gain of $70.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingRealizedGain · last filed 2018-11-08
- NATURE’S SUNSHINE PRODUCTS, INC. debt securities, trading, realized gain for the quarter ending 2018-09-30 was $70.00K, a 37.25% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. debt securities, trading, realized gain for the quarter ending 2018-06-30 was $34.00K, a 33.33% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. debt securities, trading, realized gain for the quarter ending 2017-09-30 was $51.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. debt securities, trading, realized gain for the quarter ending 2017-06-30 was $51.00K.
| Period end | Debt Securities, Trading, Realized Gain 3 month | Debt Securities, Trading, Realized Gain 6 month | Debt Securities, Trading, Realized Gain 9 month |
|---|---|---|---|
| 2018-09-30 | $70.00K 10-Q · filed 2018-11-08 | $104.00K derived: sum of 2 quarters · filed 2018-11-08 | $103.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $34.00K 10-Q · filed 2018-08-08 | $34.00K 10-Q · filed 2018-08-08 | |
| 2017-09-30 | $51.00K 10-Q · filed 2018-11-08 | $102.00K derived: sum of 2 quarters · filed 2018-11-08 | $102.00K 10-Q · filed 2018-11-08 |
| 2017-06-30 | $51.00K 10-Q · filed 2018-08-08 | $102.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |